Evaluate Efficacy and Safety of Saxagliptin in Adult Patients With Type 2 Diabetes Inadequate Glycemic Control
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Deborah Price, MSc
AstraZeneca, Wilmington, USA
Study Chair - Peter Öhman, MD, PhD
AstraZeneca, Wilmington, USA
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Research Site
Hefei, Anhui, China
- Research Site
Beijing, China, China
- Research Site
Chongqing, China, China
- Research Site
Fuzhou, Fujian, China
- Research Site
Guangzhou, Guangdong, China
- Research Site
Shijiazhuang, Hebei, China
- Research Site
Changsha, Hunan, China
- Research Site
Nanjing, Jiangsu, China
- Research Site
Changchun, Jilin, China
- Research Site
Dalian, Liaoning, China
- Research Site
Shenyang, Liaoning, China
- Research Site
Shanghai, Shanghai Municipality, China
- Research Site
Chengdu, Sichuan, China
- Research Site
Hangzhou, Zhejiang, China
- Research Site
Tianjin, China
- Research Site
Hyderabaad, Andhra Pradesh, India
- Research Site
Bangalore, Karnataka, India
- Research Site
Mangalore, Karnataka, India
- Research Site
Mumbai, Maharashtra, India
- Research Site
Nagpur, Maharashtra, India
- Research Site
Pune, Maharashtra, India
- Research Site
Coimbatore, India
- Research Site
Cebu City, Philippines
- Research Site
Makati City, Philippines
- Research Site
Manila, Philippines
- Research Site
Marikina City, Philippines
- Research Site
Quezon City, Philippines
- Research Site
Jeonju, Jeollabuk-do, South Korea
- Research Site
Daegu, South Korea
- Research Site
Seoul, South Korea
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2008
- Primary completion
- 31 Oct 2009
- Completion
- 31 Oct 2009
- Last update posted
- 21 Sept 2011
- Registered enrollment
- 568
- Registry id
- NCT00698932
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.